Using cancer organoids, co-cultures, and in-vivo models we show that loss of BRCA function in cancer cells leads to a transcriptional shift of PSCs from myofibroblastic to immune-regulatory Clu+ CAFs in an HSF1-dependent manner. This evidence concerns the gene CLU and cancer.